• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国食品药品监督管理局对膳食补充剂的监管以及关于不良事件报告的要求。

FDA regulation of dietary supplements and requirements regarding adverse event reporting.

机构信息

Division of Dietary Supplement Programs, US Food and Drug Administration, College Park, Maryland, USA.

出版信息

Clin Pharmacol Ther. 2010 Feb;87(2):239-44. doi: 10.1038/clpt.2009.263. Epub 2009 Dec 23.

DOI:10.1038/clpt.2009.263
PMID:20032973
Abstract

In 1994, the Dietary Supplement Health and Education Act (DSHEA) amended the Federal Food, Drug, and Cosmetic Act (FDC Act) to set up a distinct regulatory framework for what we now call dietary supplements. The DSHEA was passed with the intent of striking a balance between providing consumers access to safe dietary supplements to help maintain or improve their health and giving the US Food and Drug Administration (FDA) authority to regulate and take action against manufacturers of supplements or supplement ingredients that present safety problems, are presented with false or misleading claims, or are adulterated or misbranded. This article will present FDA's recent experience in collecting and evaluating dietary supplement adverse event data for the purpose of assuring the public that the dietary supplements they purchase are safe.

摘要

1994 年,《膳食补充剂健康与教育法案》(DSHEA)修订了《联邦食品、药品和化妆品法案》(FDCA),为我们现在所说的膳食补充剂建立了一个独特的监管框架。DSHEA 的通过旨在在为消费者提供安全的膳食补充剂以帮助维持或改善他们的健康的同时,给予美国食品和药物管理局(FDA)权力来监管和对存在安全问题的补充剂或补充剂成分的制造商采取行动,这些制造商提出虚假或误导性的声明,或者是掺假或贴错标签的。本文将介绍 FDA 最近在收集和评估膳食补充剂不良事件数据方面的经验,目的是向公众保证他们购买的膳食补充剂是安全的。

相似文献

1
FDA regulation of dietary supplements and requirements regarding adverse event reporting.美国食品药品监督管理局对膳食补充剂的监管以及关于不良事件报告的要求。
Clin Pharmacol Ther. 2010 Feb;87(2):239-44. doi: 10.1038/clpt.2009.263. Epub 2009 Dec 23.
2
The importance of GRAS to the functional food and nutraceutical industries.一般认为安全(GRAS)对功能性食品和营养保健品行业的重要性。
Toxicology. 2006 Apr 3;221(1):17-27. doi: 10.1016/j.tox.2006.01.012. Epub 2006 Feb 17.
3
FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.美国食品药品监督管理局扩大上市后监管权限以监测并公布食品及消费品健康风险:在9·11后的监管环境中,需要程序保障措施来减少“透明度”政策带来的危害
Food Drug Law J. 2009;64(3):577-98.
4
Dietary supplements and lessons to be learned from GRAS.膳食补充剂以及从一般认为安全(GRAS)中吸取的教训。
Regul Toxicol Pharmacol. 2000 Feb;31(1):68-76. doi: 10.1006/rtph.1999.1369.
5
Dietary supplement adverse event reports: review and analysis.膳食补充剂不良事件报告:回顾与分析
Food Drug Law J. 2009;64(3):503-13.
6
Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?在美国,关于膳食补充剂的虚假宣传、误导性信息以及生产问题能否得到改善?
J Pharmacol Exp Ther. 2005 Sep;314(3):939-44. doi: 10.1124/jpet.105.085712. Epub 2005 Apr 15.
7
Proposed rule: current good manufacturing practice in manufacturing, packing, or holding dietary ingredients and dietary supplements.拟议规则:膳食成分及膳食补充剂生产、包装或储存中的现行良好生产规范。
Life Sci. 2006 Mar 27;78(18):2049-53. doi: 10.1016/j.lfs.2005.12.020. Epub 2006 Mar 3.
8
Structure/function claims in dietary supplement labeling: not all of these claims need to be submitted to FDA and accompanied in labeling by the DSHEA disclaimer.膳食补充剂标签中的结构/功能声明:并非所有这些声明都需要提交给美国食品药品监督管理局,并在标签中附上《膳食补充剂健康与教育法》免责声明。
Food Drug Law J. 1999;54(1):35-42.
9
Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.麻黄:昨天、《膳食补充剂健康与教育法》以及明天——对1994年《膳食补充剂健康与教育法》的十年展望
J Herb Pharmacother. 2005;5(3):67-86.
10
Marketing dietary supplements in the United States: a review of the requirements for new dietary ingredients.美国膳食补充剂的营销:新膳食成分要求综述
Toxicology. 2006 Apr 3;221(1):4-8. doi: 10.1016/j.tox.2006.01.010. Epub 2006 Feb 21.

引用本文的文献

1
A Scoping Review of Published Literature on the Contributions of the Natural Health Products (NHPs) Industry to Pharmacovigilance for NHPs.关于天然健康产品行业对天然健康产品药物警戒贡献的已发表文献的范围综述。
Drug Saf. 2025 Aug 8. doi: 10.1007/s40264-025-01587-w.
2
A multi-detector analytical approach for characterizing complex botanical extracts: a case study on ashwagandha.一种用于表征复杂植物提取物的多检测器分析方法:以印度人参为例的案例研究。
Anal Bioanal Chem. 2025 Jul 22. doi: 10.1007/s00216-025-06006-8.
3
Chondroitin Sulfate in USA Dietary Supplements in Comparison to Pharma Grade Products: Analytical Fingerprint and Potential Anti-Inflammatory Effect on Human Osteoartritic Chondrocytes and Synoviocytes.
美国膳食补充剂中的硫酸软骨素与药品级产品的比较:分析指纹图谱及其对人骨关节炎软骨细胞和滑膜细胞的潜在抗炎作用
Pharmaceutics. 2021 May 17;13(5):737. doi: 10.3390/pharmaceutics13050737.
4
Intra-Laboratory Validation of Alpha-Galactosidase Activity Measurement in Dietary Supplements.膳食补充剂中α-半乳糖苷酶活性测定的实验室内部验证。
Molecules. 2021 Mar 12;26(6):1566. doi: 10.3390/molecules26061566.
5
Safety Concerns of Skin, Hair and Nail Supplements in Retail Stores.零售商店中皮肤、头发和指甲补充剂的安全问题。
Cureus. 2020 Jul 30;12(7):e9477. doi: 10.7759/cureus.9477.
6
Proportionality in Public Health Regulation: The Case of Dietary Supplements.公共卫生监管中的比例原则:膳食补充剂案例
Food Ethics. 2018 Dec;2(1):1-16. doi: 10.1007/s41055-017-0023-3. Epub 2017 Dec 18.
7
Using natural language processing methods to classify use status of dietary supplements in clinical notes.使用自然语言处理方法对临床记录中的膳食补充剂使用状态进行分类。
BMC Med Inform Decis Mak. 2018 Jul 23;18(Suppl 2):51. doi: 10.1186/s12911-018-0626-6.
8
Selection of Priority Natural Products for Evaluation as Potential Precipitants of Natural Product-Drug Interactions: A NaPDI Center Recommended Approach.优先选择天然产物作为评价其是否为天然产物-药物相互作用潜在沉淀剂的研究对象:NaPDI 中心推荐方法。
Drug Metab Dispos. 2018 Jul;46(7):1046-1052. doi: 10.1124/dmd.118.081273. Epub 2018 May 7.
9
Mining Adverse Events of Dietary Supplements from Product Labels by Topic Modeling.通过主题建模从产品标签中挖掘膳食补充剂的不良事件
Stud Health Technol Inform. 2017;245:614-618.
10
Effect of cranberry dietary supplements with different brands on human CYP3A4 enzyme.不同品牌蔓越莓膳食补充剂对人CYP3A4酶的影响。
EXCLI J. 2012 Mar 28;11:108-15. eCollection 2012.